NEW YORK – Natera said last week that the US Patent Office has upheld all claims of one of its patents that were under scrutiny in an inter partes review initiated by Illumina in 2019.
NEW YORK – Natera said last week that the US Patent Office has upheld all claims of one of its patents that were under scrutiny in an inter partes review initiated by Illumina in 2019.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.